RBC Cuts Galapagos NV Target Price to $28, Maintains Sector Performance Assessment

RBC has revised its target price for Galapagos NV (GLPG) to $28, a level it has retained in light of expectations for the company’s first‑quarter earnings report. The analysis notes that the firm’s current financial performance and recent developments in its product portfolio have prompted a downward adjustment of the target price. The new $28 target represents a substantial retreat from the previous $32 level. RBC continues to classify Galapagos NV in the sector performance category, indicating that the company possesses moderate growth potential relative to the sector average. For investors, this update highlights the importance of closely monitoring market expectations and the company’s strategic plans as the first‑quarter results are awaited. This is not investment advice.

📊 RBC — Piyasa Yorumu

▼ down · 60%

RBC's price target reduction for Galapagos NV reflects the investment bank's cautious stance on the biotechnology sector. Although the stock has declined 1.8% in the last 24 hours, the RSI remains neutral at 54. The MACD line is below the signal line, but the gap is narrowing, indicating weakening momentum without a clear bearish signal yet. The short-term outlook is slightly bearish due to mixed technical signals and negative sentiment from the news.

RSI 14

54.2

MACD

-0.85

24h Δ

-1.80%

Canlı Grafikler